Unit 8: Protein Distribution + Transport, Edoplasmic Reticulum, Golgi Apparatus + Lysosomes Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Basics

A
  • Eukaryotic cells characterised by presence if membrane bound organelles in cytoplasm, in which specific activities efficiently occur
  • Protein transport between different organelles is complex process
  • Proteins destined for endoplasmic reticulum (ER), Golgi apparatus (AG), lysosomes (L), plasma membrane and to be secreted are synthesised in ribosomes bound to the ER membrane
  • In ER, folding + processing of proteins take place
  • From ER, proteins are transported in vesicles to the AG, where they are further processed + distributed for transport to lysosomes, plasma membrane or to be secreted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Endoplasmic reticulum

8.1

A

Membrane surrounded network of tubules + sacs extending from nuclear membrane to entire cytoplasm

  • Surrounded by continuous membrane
  • Membrane = *50% of all cell membranes + *lumen (cistern space) = 10% of all cell volume
  • *Rough ER (RER): associated with ribosomes on its outer (cytosolic) face + involved in protein synthesis + processing
  • *Smooth ER (SER): does not associate with ribosomes, involved in lipid metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RER + protein secretion, Label chairing experiment

8.1

A

Pancreatic afinar cells (secrete most de novo synthesised proteins in digestive tract) labelled with radioactive aa to study intracellular pathway used by secreted proteins

  • After short incubation period with radioactive aa (3min label), autoradiography revealed that de novo synthesised proteins localised in RER.
  • After subsequent incubation with non-radioactive aa (chasing), proteins moved from ER to AG then, inside vesicles, to plasma membrane and to outside of cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • *General scheme of protein distribution in mammals

8. 1

A
  • *Protein synthesised on free ribosomes: remain in cytosol or transported to nucleus, mitochondri, chloroplasts or peroxisomes
  • *Proteins synthesised in RER: translocated directly into ER via *translocon (protein complex that forms channel for proteins to be introduced to ER). Can be retained within or be transported to nuclear membrane, peroxisomes or AG. From AG can be moved to endosomes, lysosomes, plasma or outer membranes via secretory vesicles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • Labelling of proteins to target ER

8. 1

A
  • Proteins translocated to ER during synthesis on membrane bound ribosomes (cotranslational translocation) or once translation completed on free ribosomes in cytoplasm (post-translational translocation)
  • Mammals:most proteins enter ER via cotranslational, Yeast: both pathways used
  • 1st step of cotranslational pathway is association of *ribosome-mRNA complex with ER
  • ‘tag’ that determines ribosome binds to ER membrane contained in primary sequence of aa of polypeptide chain being synthesised, not sue to intrinsic ribosome properties
    • Free + membrane-bound ribosomes are functionally indistinguishable. All protein synthesis begins on ribosomes free in cytosol
  • Ribosomes involved in protein synthesis to be secreted labelled for targeting ER by *signal sequence located at *amino terminus of growing chain.
  • Signal sequence = hydrophobic aa cleaved from polypeptide chain during transfer to ER
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Experiment that proves signal sequence

8.1

A

obtaining an *in vitro preparation of RER, for studies on direction of proteins to their appropriate locations in cell:

  • When cells breakdown, ER breaks down into small vesicles (*microsomes)
  • Large amount of RNA in ribosomes increases the density of rough microsomes
  • Güter Babel + David Sabatini (1971) proposed that signal that directed some ribosomes to ER is at amino terminal end of chain + is deleted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

*In vitro mRNA translation experiments of secretion proteins

A
  • When translation occurs in free ribosomes they gave rise to slightly larger proteins, compared to normal secreted proteins.
  • When microsomes added to system, polypeptide chains were incorporated into microsomes + signal sequence was removed by proteolytic cleavage, producing a protein of the expected size
  • *signal sequence contains between 15-40aa, incl. strip of 7-12 hydrophobic aa, usually at amino terminal end of chain, preceded by basic aa like Arginine (Arg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Steps of cotranslational translocation of secretion proteins to the ER
    8. 1
A
  1. As they exit ribosome, sequences recognised + attached to a signal recognition particle (SRP) made up of 6 polypeptides + a small cytoplasmic RNA.
  2. SRP stops translation + accompanies complex to ER membrane, where it binds to SRP receptor.
  3. SRP release + ribosome binds to translocon. Insertion of signal opens translocon.
  4. Translation resumes + signal sequences cleaved by signal peptidase.
  5. Translation continues, driving translocation of growing polypeptide chain across membrane.
  6. Polypeptide released into lumen of ER.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Other info about cotranslational translocation of secretion proteins to ER
8.1

A
  • Yeast + mammals: *translocons that cross ER membrane are complexes of 3 transmembrane proteins called *Sec61
  • Insertion of signal sequence opens translocon by removing plug from translocational channel, allowing growing chain to be transferred through translocon as translation continues
  • Process of protein synthesis directly produces transfer of nascent polypeptide chains through translocon to ER.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • Post-translational translocation

8. 1

A
  • Proteins translated by cytosolic ribosomes then targeted to ER (*occurs in many yeast proteins).
  • Does not require SRP.
  • Signal sequences recognised by *Sec62/63 complex associated with translocon in ER membrane.
  • Hsp70 chaperones required to maintain polypeptide chains in their primary conformation so they can penetrate the translocon.
  • Other Hsp70 chaperones within ER (called BiP) associated with Sec63 are necessary to allow chain to cross channel into ER.
  • Many BiP molecules bind to chain as they undergo translocation to ER, preventing sliding backwards + propelling them through channel.
  • Release of BiP molecules linked to hydrolysis of ATP.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
    • How are the 2 translocation pathways activated?

8. 1

A
  • Post-translational translocation activated by BiP (type of Hsp70 chaperones in ER)
  • Cotranslational translocation directly driven by protein synthesis process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Insertion of proteins into ER membrane

8. 1

A
  • Proteins destined to be secreted or reside in ER lumen, Golgi apparatus or lysosomes translocated + released into ER lumen.
    • Proteins destined to be incorporated into plasma membrane or ER membrane, Golgi or lysosomes are initially *inserted into ER membrane rather than being released into ER lumen.
  • From ER membrane they continue to final destination by same route as secreted proteins (ER - Golgi - plasma membrane or lysosomes), but are transported along this route as components of membrane instead of soluble proteins.
  • Integral membrane proteins embedded in membrane by hydrophobic regions that cross lipid membrane
  • Regions of protein that. Cross the lipid bilayer are usually α-helix regions made of up to 20-25 hydrophobic aa
  • Formation of α-helix:
    • maximises H bods between peptide bonds
    • hydrophobic side chains of aa interact with fatty acid tails of phospholipids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • How various integral membrane proteins differ in how inserted
    8. 1
A
  • Some cross membrane once, others have multiple regions that cross membrane.
  • Some proteins oriented with carboxyl-terminal end on cytosolic side; others have amino-terminal exposed on cytosolic side.
  • Most inserted via cotranslational pathway.
  • Orientation of inserted protein membranes is established as growing polypeptide chains translocated into ER.
  • ER lumen is topologically equivalent to outside of cell, so domains of plasma membranes that are exposed on cell surface correspond to regions of polypeptide chain that are translocated inside ER.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • Internal transmembrane sequences

8. 1

A
    • Many proteins inserted directly into ER membrane via these sequences. Recognised + translocated by SRP, but not cleaved by signal peptidase. In these cases no amino-terminal signal recognised by SRP, but instead recognises internal (transmembrane) signal sequence
    • Helicase chain exits translocon + binds the protein to ER membrane
  • Hydrophobic transmembrane sequence indicates change in translocon, causing hydrophobic transmembrane domain of protein to exit translocon into lipid bilayer
  • Depending on transmembrane signal sequences, proteins inserted into membrane by this mechanism may have amino or carboxyl end exposed in cytosol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • How do transmembrane sequences affect which end is exposed in the cytosol
    8. 1
A
  • A) Internal transmembrane sequence directs insertion of the polypeptide so amino (N) end is exposed on cytosolic side:
  • Transmembrane sequence exits translocon to fix protein in lipid bilayer and rest of chain is translocated to ER as translation proceeds.
  • B) Internal transmembrane sequence directs insertion of polypeptide so its carboxyl terminus (C) is exposed on cytosolic side:
  • Other internal transmembrane sequences oriented to direct transfer of amino-terminal part of polypeptide across membrane. Continuous translation produces a protein with its N end in lumen + C end in cytosol.
  • C) Insertion of membrane protein with cleanable signal sequence + an internal transmembrane sequence:
  • Signal sequence is cleaved when chain crosses the membrane. N end is exposed in ER lumen. Translocation interrupted when translocon recognises a transmembrane sequence. Protein exits translocon laterally + binds to ER. Translation continues + C end remains on cytosolic Sid.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • Alternative mechanism of transmembrane protein insertion

8. 1

A
  • Some proteins with *carboxyl end exposed in cytosol inserted into ER membrane via *alternative mechanism
  • Proteins have a *normal amino terminal sequence, which is cleaved by signal peptidase during translocation of chain through translocon
  • Growing amino-terminal part of polypeptide is translocated into ER as translation proceeds
  • Translocation of polypeptide interrupted by *α-helix in middle of protein, which binds to the polypeptide to membrane
  • Exit of this extended helix to membrane of translocon blocks subsequent translocation of the polypeptide. Carboxyl-terminal of developing chain remains in cytosol
17
Q

*Proteins inserted into membrane multiple times

A
    • Some proteins inserted multiple times as a consequence of transmembrane sequences with alternate orientation
  • Internal transmembrane sequences can lead to insertion into membrane of polypeptide chain with it amino terminus of cytosolic side
  • Translation continues, thus the synthesis of chain occurs in ER lumen
  • If a 2nd membrane sequence is found, the growing chain will insert back into ER, to form another looped domain, this time on cytosolic side of membrane
  • Process can be repeated many times
18
Q

Insertion of proteins with transmembrane sequence at carboxyl end

A
    • Proteins with a transmembrane sequence at carboxyl end are inserted into ER membrane by alternative post-translational pathway.
  • *Proteins cannot be recognised by SRP, their transmembrane domain does not emerge from ribosome until translation is complete + entire chain is released from ribosome.
  • Transmembrane domains targeted by targeting factor called *TRC40 or GET3, where it inserts through the GET1-GET2 receptor.
19
Q
  • Name all 5 ways integral proteins differ in insertion method
    8. 1
A
  1. Internal transmembrane sequence directs insertion of polypeptide so that amino (N) end is exposed on cytosolic side.
  2. Internal transmembrane sequence directs the insertion of the polypeptide so that its carboxyl terminus (C) is exposed on cytosolic side
  3. Insertion of a membrane protein with a cleavable signal sequence + an internal membrane sequence
  4. Proteins that insert into membrane several times as consequence of transmembrane sequences with alternate orientation
  5. Post-translational insertion of protein with a C-terminal transmembrane sequence
20
Q
  • Protein folding + processing in the ER

8. 1

A
  • In case of secretory proteins, many processes occur during translocation across ER membrane or into ER lumen
  • One process is cleavage of signal sequence peptide as the polypeptide chain translocated across the ER membrane
  • ER processes:
    • protein folding
    • assembly of proteins from various subunits (quaternary structure)
    • disulfide bond formation
    • N-Glycosylation
    • addition of Glycolipids anchors (to some proteins on plasma membrane)
  • Main role of ER lumen proteins is to catalyse folding + assembly of translocated polypeptides
21
Q

Protein folding in the ER

8.1

A
  • Proteins translocated across ER membrane as an unfolded chain while translation proceeds
  • Polypeptides fold in their 3 dimensional conformation in the ER, assisted by *chaperones that *facilitate folding of chains
  • *Hsp (BiP) chaperones bind to unfolded chain as it traverses the membrane, then mediates protein folding + assembly of multi-subunit proteins within ER
  • Correct assembled proteins released from BiP + other chaperones, thus available for transport to Golgi apparatus
22
Q

*Formation of disulfide bonds between side chains of Cys residues

A
  • *disulfide bonds do not usually form in cytosol, characterised by a reducing environment that maintains most of Cys residues in their reduced state (-SH)
    • In ER, its oxidising environment, promotes formation of disulfide bonds (S-S)
  • Formation of disulfide bonds is favoured by *disulfide isomerase that is located in ER lumen
23
Q

*Proteins glycosylated at asparagine residues (N-Glycosylation)

A
  • *oligosaccharide units consisting of 14 sugar residues (monosaccharides) added to the Asn residues of growing polypeptide chains while being tranlsocated
  • Oligosaccharide synthesised on *lipid transporter (Dolichol)
  • Oligosaccharide transferred as a unit to the acceptor Asn residues in consensus sequence Asn-X-Ser/Thr by *oligosaccharyl-transferase
  • 3 glucose residues are removed while the protein remains in the ER lumen. The proteins undergo further modification in the Golgi apparatus
  • Glycosylation prevents *protein aggregation in the ER, adding signals that *promote protein folding + subsequent *distribution in secretory pathway
24
Q
  • Proteins anchored by glycolipids

8. 1

A
  • membrane-anchored glycolipids contain phosphatidylinositol, they are called *glycosylphosphatidylinositol (GFI) anchors
  • GFI anchors contain 2 fatty acid chains, an oligosaccharide residue consisting of inositol + other sugars, + ethanolamine
  • ## *C-terminal sequence of protein cleaved + exchanged by GFI anchor, so these proteins only anchored to membrane by glycolipid bond
25
Q

Quality control in ER

8.1

A
  • Many proteins synthesised in ER are rapidly degraded, mainly because they do not fold correctly
  • Misfolded proteins are removed from ER by *ER-associated degradation (ERAD), where *misfolded proteins are identified + leave ER to cytosol, where they are *degraded by ubiquitin-proteasome system
26
Q

Pathway of glycoprotein folding related to chaperones

A
  • *Calnexin + *Calreticulin recognise partially processed oligosaccharides, from which 2 terminal glucose residues have been removed
  • Chaperones facilitate folding of glycoprotein to correct conformation
  • Glycoprotein released by removal of 3rd terminal glucose residue from oligosaccharide
  • Protein folding sensor that monitors whether protein has reach fully folded state (absence of hydrophobic regions) recognises the glycoprotein
  • If folding adequate, protein continues to Golgi apparatus
  • If not, folding sensor adds a glucose residue to oligosaccharide, going into new cycle with either chaperone for another attempt of folding
  • If doesn’t fold correct after several cycles, protein directed to *ERAD pathway for degradation
  • Protein with folding defects recognised by EDEM1 which removes mannose residues from oligosaccharide
  • Removal f mannose prevents folding defective glycoprotein being returned to chaperones, causing them to be transferred to transmembrane complex with *ubiquitin-ligase activity
  • Then translocated to cytosol where ubiquitylation + degraded by *proteasomes